Here are three relevant quotes from Jon in the webinar relating to Phase 3 trials. I've included time-stamped links so you can hear it from Jon's mouth, but I'd strongly recommend that people listen to the entire webinar as it contains a lot of valuable information.
“There’s no doubt that if you can do it you ‘ll create huge amount of value compared to now…”https://youtu.be/hO6z4VoEs8k?si=K7bj1Ua74VnrFDu-&t=1783
“Estimated cost, I’ve said publicly a number of times that I think for each indication I think between $50m and $150m US dollars is the right range per indication. We’ll hone that down once we have some certainty on the trial design”
https://youtu.be/hO6z4VoEs8k?si=F0Pyk-2j7O4v-lP-&t=2081
“I think with our financial position that Dabue has given us that we can comfortably fund two indications ourselves, probably not more, with the current financial resources… through Phase 3”
NEU is materially undervalued, page-12
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.70 |
Change
-0.310(2.38%) |
Mkt cap ! $1.623B | |||
| Open | High | Low | Value | Volume |
| $12.80 | $12.90 | $12.69 | $5.154M | 403.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4631 | $12.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.76 | 1060 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |